Consolidated Statements of Stockholders' Equity (USD $) In Thousands, except Share data, unless otherwise specified	Total USD ($)	Common Stock [Member] USD ($)	Treasury Stock [Member] USD ($)	Additional Paid-in Capital [Member] USD ($)	Accumulated Other Comprehensive Income (Loss) [Member] USD ($)	Retained Earnings (Accumulated Deficit) [Member] USD ($)	Non-controlling Interests [Member] USD ($)	Florida Chemical Company, Inc [Member] USD ($)	Florida Chemical Company, Inc [Member] Common Stock [Member] USD ($)	Florida Chemical Company, Inc [Member] Additional Paid-in Capital [Member] USD ($)	EOGA [Member] USD ($)	EOGA [Member] Common Stock [Member]	EOGA [Member] Additional Paid-in Capital [Member] USD ($)	SiteLark [Member] USD ($)	SiteLark [Member] Common Stock [Member]	SiteLark [Member] Additional Paid-in Capital [Member] USD ($)
Beginning balance at Dec. 31, 2011	$ 78,298	$ 5	$ (1,667)	$ 166,814	$ (44)	$ (86,810)
Beginning balance, shares at Dec. 31, 2011		51,958,000	1,358,000
Increase (Decrease) in Stockholders' Equity
Net income	49,791					49,791
Foreign currency translation adjustment	4				4
Common stock issued in payment of accrued liability	0
Fair value of warrant liability reclassified to additional paid-in-capital	13,973			13,973
Stock issued under employee stock purchase plan	161			161
Stock issued under employee stock purchase plan, shares			(15,000)
Stock warrants exercised	421			421
Stock warrants exercised, shares	348,350	348,000
Stock options exercised	167			167
Stock options exercised, shares		68,000
Restricted stock granted, shares		750,000
Restricted stock forfeited, shares			30,000
Treasury stock purchased	(2,034)		(2,034)
Treasury stock purchased, shares			166,000
Excess tax benefit related to share-based awards	528			528
Stock compensation expense	13,421			13,421
Return of borrowed shares under share lending agreement			659,000
Ending balance at Dec. 31, 2012	154,730	5	(3,701)	195,485	(40)	(37,019)
Ending balance, shares at Dec. 31, 2012		53,124,000	2,198,000
Increase (Decrease) in Stockholders' Equity
Net income	36,178					36,178
Foreign currency translation adjustment	(319)				(319)
Common stock issued in payment of accrued liability	0
Common stock issued in payment of accrued liability, shares	0
Fair value of warrant liability reclassified to additional paid-in-capital	0
Issuance cost of preferred stock an detachable warrants	(200)			(200)
Stock issued under employee stock purchase plan	824			824
Stock issued under employee stock purchase plan, shares			(44,000)
Stock warrants exercised	323			323
Stock warrants exercised, shares	267,000	267,000
Stock options exercised	4,397			4,397
Stock options exercised, shares	571,500	572,000
Restricted stock granted, shares	802,164	802,000
Restricted stock forfeited, shares			115,000
Stock granted in incentive performance plan, shares		217,000
Treasury stock purchased	(7,568)		(7,568)
Treasury stock purchased, shares	448,121		448,000
Stock surrendered for exercise of stock options	(3,907)		(3,907)
Stock surrendered for exercise of stock options, shares	237,267		237,000
Excess tax benefit related to share-based awards	1,668			1,668
Stock compensation expense	10,914			10,914
Stock issued in acquisition								52,712	1	52,711
Stock issued in acquisition, shares								3,284,180	3,284,000
Return of borrowed shares under share lending agreement			2,440,000
Retirement of Treasury Stock, shares	0
Ending balance at Dec. 31, 2013	249,752	6	(15,176)	266,122	(359)	(841)
Ending balance, shares at Dec. 31, 2013		58,266,000	5,394,000
Increase (Decrease) in Stockholders' Equity
Net income	53,603					53,603
Foreign currency translation adjustment	(143)				(143)
Common stock issued in payment of accrued liability	600			600
Common stock issued in payment of accrued liability, shares	27,101	27,000
Fair value of warrant liability reclassified to additional paid-in-capital	0
Stock issued under employee stock purchase plan	906			906
Stock issued under employee stock purchase plan, shares			(43,000)
Stock warrants exercised	1,545			1,545
Stock warrants exercised, shares	1,277,250	1,277,000
Stock options exercised	1,660			1,660
Stock options exercised, shares	311,954	312,000
Restricted stock granted, shares	525,120	526,000
Restricted stock forfeited, shares			61,000
Stock granted in incentive performance plan, shares		0
Treasury stock purchased	(6,294)		(6,294)
Treasury stock purchased, shares	243,005		243,000
Stock surrendered for exercise of stock options	(1,198)		(1,198)
Stock surrendered for exercise of stock options, shares	46,208		46,000
Excess tax benefit related to share-based awards	3,448			3,448
Stock compensation expense	10,476			10,476
Investment in Flotek Gulf, LLC and Flotek Gulf Research, LLC	351						351
Stock issued in acquisition											1,894		1,894	149		149
Stock issued in acquisition, shares								0				94,000			5,000
Repurchase of common stock	(10,395)		(10,395)
Repurchase of common stock, shares			621,000
Retirement of Treasury Stock		(1)	32,568	(32,567)
Retirement of Treasury Stock, shares	(5,873,291)	(5,873,000)	(5,873,000)
Ending balance at Dec. 31, 2014	306,354	5	(495)	254,233	(502)	52,762	351
Ending balance, shares at Dec. 31, 2014		54,634,000	449,000
Beginning balance at Dec. 30, 2014	306,354	5	(495)	254,233
Beginning balance, shares at Dec. 30, 2014		54,634,000	449,000
Increase (Decrease) in Stockholders' Equity
Retirement of Treasury Stock	$ (32,600)	$ (1)	$ 32,600	$ (32,600)
Retirement of Treasury Stock, shares	(5,873,291)
Ending balance at Dec. 31, 2014